Diamedica Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Diamedica Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Diamedica Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Diamedica Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $487 | 172 | 2.84 |
| 2023-09-30 | $420 | 163 | 2.58 |
| 2023-06-30 | $501 | 116 | 4.32 |
| 2022-12-31 | $173 | 110 | 1.58 |
| 2022-09-30 | $0 | 107 | 0.00 |
| 2022-06-30 | $0 | 177 | 0.00 |
| 2022-03-31 | $0 | 163 | 0.00 |
| 2021-12-31 | $999 | 162 | 6.17 |
| 2021-09-30 | $0 | 115 | 0.00 |
| 2021-06-30 | $0 | 105 | 0.00 |
| 2021-03-31 | $1.0k | 106 | 9.43 |
| 2020-12-31 | $20k | 2.1k | 9.43 |
| 2020-09-30 | $0 | 2.1k | 0.00 |
| 2020-06-30 | $0 | 2.1k | 0.00 |
| 2020-03-31 | $0 | 67 | 0.00 |